AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or bothOPEN ACCESS
BMJ · DOI: 10.1136/bmj.j4008
BMJ · 12 October 2016
Sets out ROBINS-I, a tool for assessing risk of bias in estimates of intervention effects from non-randomised studies. Each study is compared against a hypothetical target randomised trial across seven bias domains, making it a widely used companion to RoB 2 in evidence synthesis.
Summary written by Sterling IMRES editors. Read the original abstract at the publisher.
The full author list is available from the publisher.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;i4919. doi:10.1136/bmj.i4919
BMJ · DOI: 10.1136/bmj.j4008
BMJ · DOI: 10.1136/bmj.n71